COMING SOON: Bispecifics in Multiple Myeloma: Payer Perspectives

home / training-academy / bispecifics-in-multiple-myeloma-payer-perspectives

Expert panelists share experiences and best practices from a payer perspective regarding the use of bispecifics in patients with multiple myeloma.

Expert on multiple myeloma

EP. 1: COMING SOON: Bispecifics in Multiple Myeloma: Payer Perspectives

Cesar R. Valdes, MD
April 20th 2023

Cesar R. Valdes, MD, shares his excitement for an upcoming program centered on payer perspective regarding the use of bispecifics in patients with multiple myeloma.